- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06721780
AR Vs VR in Burns Dressing Changes (AR vs VR)
December 3, 2024 updated by: Buckinghamshire Healthcare NHS Trust
For children with burn injuries, changing their dressings can be one of the most traumatising experiences of their treatment journey.
This process is not only distressing for the children but also for their parents and the healthcare professionals involved.
Current methods to reduce this trauma include the use of play therapists, but such resources are often limited.
There is good evidence that Augmented Reality (AR) and Virtual Reality (VR) can help by providing a distracting and immersive environment that eases pain and fear.
However, no studies have yet compared these two modern technologies to see which is more effective
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
90
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: James Cooper, BSc, MSc
- Phone Number: 07816020305
- Email: james.cooper9@nhs.net
Study Contact Backup
- Name: Akshat Sawhney, MBBS BSc MRCS
- Phone Number: 01296 831378
- Email: bht.research@nhs.net
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
• Participants presenting with guardians with parental responsibility, who are willing and able to consent to recruitment.
- Aged 4-17 years
- Presenting with burns requiring a dressing change, on their first attendance to the burns clinic.
- Participating child is able to complete the FACES Pain Scale
Exclusion Criteria:
• Children aged 4 or below
- Those with severe cognitive impairment, visual disorders, facial burns or other conditions preventing the safe use of VR/AR technology.
- Previous 'cybersickness' symptoms (nausea, dizziness).
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Standard care
This is standard care (what they would normally receive if they were not enrolled into this study)
|
|
|
Active Comparator: Participants randomised to wear AR headset
AR headset: MagicLeap 2 - running Divertini's "Watering Plants" world.
|
Participants will use an AR headset that employs a distraction game specifically designed for children and young adults undergoing painful procedures.
|
|
Active Comparator: Participants randomised to wear VR headset
VR Headset: Oculus Quest 2 - Running SyncVR's Relaxation and Pain control simulations
|
Participants will utilise a VR headset, running a calming virtual environment or an interactive game during the dressing change.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
determine the relative performance
Time Frame: 2 hours
|
To determine the relative performance of AR and VR in pain and anxiety control during burns dressings changes in comparison to standard of care. Objective measures: Pulse rate, Respiratory rate |
2 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
February 1, 2025
Primary Completion (Estimated)
January 1, 2026
Study Completion (Estimated)
February 1, 2026
Study Registration Dates
First Submitted
November 26, 2024
First Submitted That Met QC Criteria
December 3, 2024
First Posted (Estimated)
December 6, 2024
Study Record Updates
Last Update Posted (Estimated)
December 6, 2024
Last Update Submitted That Met QC Criteria
December 3, 2024
Last Verified
November 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- RXQ 1136
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Burns Multiple
-
Riphah International UniversityActive, not recruiting
-
The Hong Kong Polytechnic UniversityCompleted
-
Academisch Medisch Centrum - Universiteit van Amsterdam...CompletedMechanical Ventilation | Burns - MultipleNetherlands
-
Indiana UniversityEskenazi HealthCompletedBurns | Thermal Burn | Burns Multiple | Burn InfectionUnited States
-
Synochi, LLCLAC+USC Medical CenterNot yet recruitingBurns Multiple
-
University of California, IrvineNational Institute of General Medical Sciences (NIGMS)RecruitingSkin Burn MultipleUnited States
-
University Hospital HeidelbergBG Trauma Center LudwigshafenCompletedBurns | TraumaGermany
-
Fondation Ophtalmologique Adolphe de RothschildNot yet recruiting
-
Massachusetts General HospitalCompletedBurns | Trauma | Multiple Organ FailureUnited States
-
Massachusetts General HospitalCompletedBurns | Trauma | Multiple Organ FailureUnited States
Clinical Trials on Participants randomised to wear AR headset
-
Ava AGUniversity Hospital, Zürich; Empa, Swiss Federal Laboratories for Materials... and other collaboratorsCompleted
-
Institut de Médecine et d'Epidémiologie Appliquée...ANRS, Emerging Infectious DiseasesWithdrawnHIV1 Infection | Multi-treated Patients Who Have Received Multiple Lines of Antiretroviral Treatment | CABOTEGRAVIR | LENACAPAVIR | Stable Oral Antiretroviral Treatment for at Least 6 MonthsFrance
-
China Medical University HospitalCompletedSports | Visual Perception | Eye Movements | Psychomotor PerformanceTaiwan